Nov 4, 2026 | Dietary Supplements, Drugs, Foods, Medical Devices, On Demand Webinar
Foreign entities who operate in US FDA-regulated industries must have an appointed FDA US agent before they can import products into the US. At a minimum these FDA US agents provide the most basic of required services. However, agents with relevant experience and knowledge can provide much more.
Oct 30, 2026 | Drug and Device Corner, Drugs, Medical Devices
REMINDER: The drug and medical device establishment registration renewal and listing certification period is underway. Private Label Distributors that manage their own NDC listing submissions should be aware of the listing certification process. Deadline is 31...
Sep 29, 2026 | Drug and Device Corner, Drugs, Medical Devices
NDC format change is coming. Although there is a seven-year delayed implementation, time does fly. Six months have already passed since announcement of this regulation on 5 March 2026. If you have not yet begun to discuss internally how these changes will be managed,...
Sep 8, 2026 | FDA and USDA Regulatory Update, Medical Devices
FDA Updates Lists of Medical Devices Incorporating Digital Health Technology The U.S. Food and Drug Administration (FDA) has updated its searchable lists of medical devices incorporating digital health technologies that have been authorized for marketing in the United...
Aug 25, 2026 | Drug and Device Corner, Drugs, Medical Devices
FDA has announced the OMUFA facility user fee amounts for FY2027 in the Federal Register Vol 91, No. 145 Over-the-Counter Monograph Drug User Fee Rates for Fiscal Year 2027. Please note the change in due date from previous years. FY2027 marks the transition to...
Jul 27, 2026 | Drug and Device Corner, Drugs, Medical Devices
Highlighted Guidance Documents Formal Meetings Between the Food and Drug Administration and Sponsors or Requestors of Over-the-Counter Monograph Drugs The Food and Drug Administration is announcing the availability of a final guidance for industry titled “Formal...